In doing so and when compared to other blastemal tumors, we identified upregulated expression of the gene encoding the non-canonical WNT ligand WNT5A in both chemotherapy-naïve and chemotherapy-treated blastemal Wilms tumors harboring the SIX1-Q177R mutation. Here, WNT5A is linked to Wilms tumor.